ArticleInvestigational new drugs2012
The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.
Miguel Muñoz et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it